PLENARY KEYNOTE SESSIONS
Tuesday, January 20 | 4:30 - 5:40 PM
4:40 - 4:50 PM From Targets to Biologics: AI Powering the Next Leap in Discovery at Takeda
Yves Fomekong Nanfack, PhD, Head of AI/ML Research, Takeda
4:50 – 5:00 PM Agentic AI for Biologics: Scalable Infrastructure for GxP-Compliant, Insight-Driven Testing
Lieza Danan, PhD, Founder & CEO, LiVeritas
5:00 – 5:10 PM Technological Trends Shaping the Landscape of Biopharmaceuticals
Aline de Almeida Oliveira, PhD, Competitive Intelligence Advisor (AICOM), Bio-Manguinhos/Fiocruz, Brazil
5:10 – 5:40 PM PLENARY FIRESIDE CHAT
Moderator: John K. Kawooya, PhD, Private Consultant, Robotics-Plate-Based-Ultra-HT Biologics Purification
Panelists:
Yves Fomekong Nanfack, PhD, Head of AI/ML Research, Takeda
Lieza Danan, PhD, Founder & CEO, LiVeritas
Aline de Almeida Oliveira, PhD, Competitive Intelligence Advisor (AICOM), Bio-Manguinhos/Fiocruz, Brazil
Wednesday, January 21 | 1:10 - 1:45 PM
Moderator: Ian Hunt, PhD, Global Head of Scientific Engagement Strategy, Novartis Pharma AG
Panelists:
Henry C. Chiou, PhD, Senior Director General Manager, Biosciences, Thermo Fisher Scientific (Recently Retired)
Nicola Burgess-Brown, PhD, Professorial Research Fellow, UCL, London; COO, Protein Sciences, Structural Genomics Consortium
Dominic Esposito, PhD, Senior Director, Protein Sciences, Septerna
Deborah Moore-Lai, PhD, Vice President, Protein Sciences, ProFound Therapeutics
David W. Wood, PhD, Professor, Chemical & Biomolecular Engineering, Ohio State University
Thursday, January 22, 2026 | 8:25 - 9:30 AM
8:25 AM Welcome Remarks
Christina Lingham, Executive Director, Conferences and Fellow, Cambridge Healthtech Institute
8:35 - 9:00 AM New Frontier of Biotherapeutic Discovery: Where Machine Learning Meets Molecular Design
Stephanie Truhlar, PhD, Vice President, Biotechnology Discovery Research, Eli Lilly and Company
9:00 - 9:30 AM PLENARY FIRESIDE CHAT: End-to-End in silico-Designed Biologics
Moderator: Andrew Nixon, PhD, Senior Vice President, Global Head Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals Inc.
Panelists:
Charlotte M. Deane, PhD, Professor, Structural Bioinformatics, Statistics, University of Oxford; Executive Chair, Engineering and Physical Sciences Research Council (EPSRC)
Garegin Papoian, PhD, Co-Founder & CSO, DeepOrigin
Stephanie Truhlar, PhD, Vice President, Biotechnology Discovery Research, Eli Lilly and Company